In August 2010, Osteotech Inc was acquired by medical device giant Medtronic Inc. Osteotech had provided services and products primarily focused in the repair and healing of the musculoskeletal system. Marketed to the orthopedic, neurological, oral/maxillofacial, dental andgeneral surgery markets in the United States and Europe. the firm's products are based on the Company's knowledge of the allograft bone tissue industry as the world's largest processor and developer of human bone and bone connective tissue (allograft bone tissue) products. The allograft bone tissue processed by Osteotech procured by independent tissue banks primarily through the donation of tissue from deceased human donors and is used for transplantation. The Company's two primary operating segments were the Grafton Demineralized Bone Matrix segment and the Base Allograft Bone Tissue segment.
